Candidate Screening & Feasibility Studies For Emerging Biotechs Developing Viral Gene Therapies

To meet the demands of the early phase market, flexible viral vector Drug Candidate Screening and Feasibility Studies can help companies and research institutions quickly overcome preclinical and Phase I hurdles such as budget and timeframe constraints. The aim of the early phase assessment studies is to create a simple, modular path to cGMP manufacturing that minimizes risk and streamlines drug substance and drug product manufacture for the clinic.

This presentation focuses on this strategic, effective approach for early stage development and how it can propel therapies to the clinic and the market.

Discover:

• What Candidate Screenings and Feasibility Studies involve
• What a modular approach looks like and what its benefits are
• How this can facilitate a faster path to cGMP